Literature DB >> 16794254

Impaired dendritic-cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination.

Stephane T Temmerman1, Chi A Ma, Louis Borges, Marek Kubin, Shuying Liu, Jonathan M J Derry, Ashish Jain.   

Abstract

Ectodermal dysplasia with immune deficiency (EDI) is caused by alterations in NEMO (nuclear factor [NF]-kappaB essential modulator). Most genetic mutations are located in exon 10 and affect the C-terminal zinc finger domain. However, the biochemical mechanism by which they cause immune dysfunction remains undetermined. In this report, we investigated the effect of a cysteine-to-arginine mutation (C417R) found in the NEMO zinc finger domain on dendritic cell (DC) function. Following CD40 stimulation of DCs prepared from 2 unrelated patients with the NEMO C417R mutation, we found NEMO ubiquitination was absent, and this was associated with preserved RelA but absent c-Rel activity. As a consequence, CD40 stimulated EDI DCs failed to synthesize the c-Rel-dependent cytokine interleukin-12, had impaired up-regulation of costimulatory molecules, and failed to support allogeneic lymphocyte proliferation in vitro. In contrast, EDI DCs stimulated with the TLR4 ligand lipopolysaccharide (LPS) showed normal downstream NF-kappaB activity, DC maturation, and NEMO ubiquitination. These findings show for the first time how mutations in the zinc finger domain of NEMO can lead to pathway specific defects in NEMO ubiquitination and thus immune deficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794254      PMCID: PMC1895566          DOI: 10.1182/blood-2006-04-017210

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node.

Authors:  Mark J Miller; Arsalan S Hejazi; Sindy H Wei; Michael D Cahalan; Ian Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-13       Impact factor: 11.205

Review 2.  The two NF-kappaB activation pathways and their role in innate and adaptive immunity.

Authors:  Giuseppina Bonizzi; Michael Karin
Journal:  Trends Immunol       Date:  2004-06       Impact factor: 16.687

Review 3.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

4.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

5.  Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.

Authors:  Tony T Huang; Shelly M Wuerzberger-Davis; Zhao-Hui Wu; Shigeki Miyamoto
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

6.  A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha.

Authors:  Eric D Tang; Cun-Yu Wang; Yue Xiong; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

7.  The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation.

Authors:  Jordan S Orange; Ashish Jain; Zuhair K Ballas; Lynda C Schneider; Raif S Geha; Francisco A Bonilla
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

8.  CD40 is required for the optimal induction of protective immunity to Mycobacterium avium.

Authors:  Manuela Flórido; Ana Sofia Gonçalves; M Salomé Gomes; Rui Appelberg
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

9.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Authors:  Lijun Sun; Li Deng; Chee-Kwee Ea; Zong-Ping Xia; Zhijian J Chen
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

10.  Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.

Authors:  Honglin Zhou; Ingrid Wertz; Karen O'Rourke; Mark Ultsch; Somasekar Seshagiri; Michael Eby; Wei Xiao; Vishva M Dixit
Journal:  Nature       Date:  2003-12-24       Impact factor: 49.962

View more
  17 in total

1.  Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO).

Authors:  Margje H Haverkamp; Beatriz E Marciano; David M Frucht; Ashish Jain; Esther van de Vosse; Steven M Holland
Journal:  J Clin Immunol       Date:  2014-02-28       Impact factor: 8.317

2.  New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein.

Authors:  Marjorie Hubeau; Flora Ngadjeua; Anne Puel; Laura Israel; Jacqueline Feinberg; Maya Chrabieh; Kiran Belani; Christine Bodemer; Isabelle Fabre; Alessandro Plebani; Stéphanie Boisson-Dupuis; Capucine Picard; Alain Fischer; Alain Israel; Laurent Abel; Michel Veron; Jean-Laurent Casanova; Fabrice Agou; Jacinta Bustamante
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

3.  Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency.

Authors:  Stephane T Temmerman; Chi A Ma; Yongge Zhao; Jeffrey Keenan; Ivona Aksentijevich; Margaret Fessler; Margaret R Brown; Alan Knutsen; Ralph Shapiro; Ashish Jain
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

4.  Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity.

Authors:  Chi A Ma; Hong-Ying Wang; Stephane Temmerman; Yongge Zhao; Liming Wu; Ronald L Hornung; Diane Wara; Ashish Jain
Journal:  Hum Mutat       Date:  2011-03       Impact factor: 4.878

5.  Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.

Authors:  Hong-Ying Wang; Chi A Ma; Yongge Zhao; Xiying Fan; Qing Zhou; Pamela Edmonds; Gulbu Uzel; Joao Bosco Oliveira; Jordan Orange; Ashish Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

6.  NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.

Authors:  E Laplantine; E Fontan; J Chiaravalli; T Lopez; G Lakisic; M Véron; F Agou; Alain Israël
Journal:  EMBO J       Date:  2009-09-17       Impact factor: 11.598

7.  Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.

Authors:  Eric P Hanson; Linda Monaco-Shawver; Laura A Solt; Lisa A Madge; Pinaki P Banerjee; Michael J May; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2008-10-11       Impact factor: 10.793

8.  CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.

Authors:  Yongge Zhao; Chi A Ma; Liming Wu; Kazuhiro Iwai; Jonathan D Ashwell; Eugene M Oltz; Dean W Ballard; Ashish Jain
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

9.  A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency.

Authors:  Eduardo Lopez-Granados; Jeffrey E Keenan; Matthew C Kinney; Harvey Leo; Neal Jain; Chi A Ma; Ralph Quinones; Erwin W Gelfand; Ashish Jain
Journal:  Hum Mutat       Date:  2008-06       Impact factor: 4.878

10.  Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency.

Authors:  Anjali Singh; Kol A Zarember; Douglas B Kuhns; John I Gallin
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.